Literature DB >> 22498326

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.

John J Green1, Jeffery S Berger, Christopher M Kramer, Michael Salerno.   

Abstract

OBJECTIVES: The objective of this study was to perform a systematic review and meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) for future cardiovascular events and death in hypertrophic cardiomyopathy (HCM).
BACKGROUND: The utility of LGE for detecting myocardial fibrosis is well established. The prognostic value of LGE in HCM has been described in several studies, but controversy exists given the limited power of these studies to predict future events.
METHODS: We searched multiple databases including PubMed for studies of LGE in HCM that reported selected clinical outcomes (cardiovascular mortality, sudden cardiac death [SCD], aborted SCD, and heart failure death). We performed a systematic review of the literature and meta-analysis to determine pooled odds ratios for these clinical events.
RESULTS: Four studies evaluated 1,063 patients over an average follow-up of 3.1 years. The pooled prevalence of LGE was 60%. The pooled odds ratios (OR) demonstrate that LGE by CMR correlated with cardiac death (pooled OR: 2.92, 95% confidence interval [CI]: 1.01 to 8.42; p = 0.047), heart failure death (pooled OR: 5.68, 95% CI: 1.04 to 31.07; p = 0.045), and all-cause mortality (pooled OR: 4.46, 95% CI: 1.53 to 13.01; p = 0.006), and showed a trend toward significance for predicting sudden death/aborted sudden death (pooled OR: 2.39, 95% CI: 0.87 to 6.58; p = 0.091).
CONCLUSIONS: Late gadolinium enhancement by CMR has prognostic value in predicting adverse cardiovascular events among HCM patients. There are significant relationships between LGE and cardiovascular mortality, heart failure death, and all-cause mortality in HCM. Additionally, LGE and SCD/aborted SCD displayed a trend toward significance. The assessment of LGE by CMR has the potential to provide important information to improve risk stratification in HCM in clinical practice.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498326     DOI: 10.1016/j.jcmg.2011.11.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  121 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 2.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

3.  Multimodal Imaging after Sudden Cardiac Arrest in an 18-Year-Old Athlete.

Authors:  Maxwell E Afari; Mobeen Ur Rehman; Michael K Atalay; Ryan J Broderick
Journal:  Tex Heart Inst J       Date:  2015-12-01

Review 4.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.

Authors:  Katherine C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792

Review 5.  Role of cardiac MRI in the assessment of nonischemic cardiomyopathies.

Authors:  Mahwash Kassi; Faisal Nabi
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jul-Sep

Review 6.  State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies.

Authors:  Balint Laczay; Divyang Patel; Richard Grimm; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

7.  Occasionally increased 18F-fluorodeoxyglucose uptake in apical hypertrophic cardiomyopathy with mid-ventricular obstruction.

Authors:  Hideya Yamamoto; Toshiro Kitagawa; Hitoshi Susawa; Ryoichiro Hata; Fuminari Tatsugami; Toru Higaki; Kazuo Awai; Yasuki Kihara
Journal:  J Cardiol Cases       Date:  2017-05-02

8.  Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.

Authors:  Jong-Chan Youn; Yoo Jin Hong; Hye-Jeong Lee; Kyunghwa Han; Chi Young Shim; Geu-Ru Hong; Young Joo Suh; Jin Hur; Young Jin Kim; Byoung Wook Choi; Seok-Min Kang
Journal:  Eur Radiol       Date:  2017-04-24       Impact factor: 5.315

9.  Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.

Authors:  Shingo Kato; Shiro Nakamori; Steven Bellm; Jihye Jang; Tamer Basha; Martin Maron; Warren J Manning; Reza Nezafat
Journal:  Am J Cardiol       Date:  2016-07-18       Impact factor: 2.778

10.  Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.

Authors:  Sabine Huke; Raghav Venkataraman; Michela Faggioni; Sirish Bennuri; Hyun S Hwang; Franz Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2013-03-26       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.